Fatty acid composition of HDL phospholipids and coronary artery disease

被引:24
作者
Noori, Mohammad [1 ]
Darabi, Masoud [1 ]
Rahimipour, Ali [1 ]
Rahbani, Mohammad [1 ]
Abadi, Naser Aslan [2 ]
Darabi, Maryam [3 ]
Ghatrehsamani, Keyhan [1 ]
机构
[1] Tabriz Univ Med Sci, Sch Med, Dept Biochem, Tabriz, Iran
[2] Tabriz Univ Med Sci, Sch Med, Dept Cardiol, Tabriz, Iran
[3] Isfahan Univ, Sch Pharm & Pharmaceut Sci, Dept Biochem, Esfahan, Iran
关键词
CAD; Fatty acids; HDL composition; HIGH-DENSITY-LIPOPROTEIN; HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; DOCOSAHEXAENOIC ACID; DIETARY-FAT; RISK; N-3; PLASMA; CHOLESTEROL;
D O I
10.1016/j.jacl.2008.11.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: The phospholipid fatty acid content of high-density lipoprotein (HDL) partially reflects that of the diet and has been reported to be associated with several important biological functions that might serve as risk markers for coronary heart disease. OBJECTIVE: To investigate whether fatty acid composition of HDL phospholipids correlates with angiographically documented coronary artery disease (CAD). METHODS: The population included 212 patients who underwent clinically indicated coronary angiography. The patients were classified with significantly diseased arteries (SDA) if one or more coronary arteries had a stenosis >50% and with minimally diseased arteries (NIDA) if there was no significant stenosis (<40%) in any artery. The severity of CAD was expressed by the number of affected vessels. The fatty acid composition of HDL phospholipids was determined by gas liquid chromatography. Multivariate analyses were used to test the independence of associations between the presence and severity of CAD as outcome variables and fatly acid composition of HDL phospholipids. RESULTS: Patients with SDA showed significantly lower levels of linoleic acid (P=.041), eicosapentaenoic acid (EPA) (P=.027), and docosahexaenoic acid (DHA) (P=.026) than patients with MDA in univariate analyses. The association of linoleic acid (odds ratio [OR].90, P<.05). EPA (OR, 0.41, P<.02), and DHA (OR, 0.48, P<.02) remained statistically significant in the multivariate analyses. The content of EPA (beta=-0.23, P<.01) and DHA (beta=-0.17, P<.05) remained inversely significantly associated with the severity of CAD. CONCLUSIONS: This study shows that polyunsaturated fatty acids. including EPA and DHA content of HDL particles, are independently associated with the presence and severity of angiographically documented CAD. 2009 National Lipid Association. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 28 条
  • [1] ASSMANN G, 1983, CLIN CHEM, V29, P2026
  • [2] Baker PW, 2000, J LIPID RES, V41, P1261
  • [3] EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls
    Block, Robert C.
    Harris, William S.
    Reid, Kimberly J.
    Sands, Scott A.
    Spertus, John A.
    [J]. ATHEROSCLEROSIS, 2008, 197 (02) : 821 - 828
  • [4] EFFECTS OF N-3 AND N-6 FATTY-ACIDS ON TUMOR-NECROSIS-FACTOR CYTOTOXICITY IN WEHI FIBROSARCOMA CELLS
    BREKKE, OL
    ESPEVIK, T
    BARDAL, T
    BJERVE, KS
    [J]. LIPIDS, 1992, 27 (03) : 161 - 168
  • [5] N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials
    Bucher, HC
    Hengstler, P
    Schindler, C
    Meier, G
    [J]. AMERICAN JOURNAL OF MEDICINE, 2002, 112 (04) : 298 - 304
  • [6] Gemfibrozil treatment potentiates oxidative resistance of high-density lipoprotein in hypertriglyceridemic patients
    Chen, MF
    Wang, TD
    Yeh, HT
    Hsu, HC
    Lee, YT
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (08) : 707 - 713
  • [7] DE CR, 2000, AM J CLIN NUTR, V71, pS213
  • [8] Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD
    Erkkila, Arja T.
    Matthan, Nirupa R.
    Herrington, David M.
    Lichtenstein, Alice H.
    [J]. JOURNAL OF LIPID RESEARCH, 2006, 47 (12) : 2814 - 2819
  • [9] Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers
    Ferrucci, L
    Cherubini, A
    Bandinelli, S
    Bartali, B
    Corsi, A
    Lauretani, F
    Martin, A
    Andres-Lacueva, C
    Senin, U
    Guralnik, JM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (02) : 439 - 446
  • [10] FOLCH J, 1957, J BIOL CHEM, V226, P497